Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis have?
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has 23 citations in the OpenAlex counts PICO Portal stores.
When was Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis published?
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has 2023 year in the PICO Portal index.
What is the open-access status of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?
Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis has gold oa status in the PICO Portal index.
What is the DOI of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?
The DOI for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.
What is the PMID of Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?
The PMID for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.
What is the OpenAlex record for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis?
The OpenAlex for Inflammatory bowel disease and prostate cancer risk: a two-sample Mendelian randomization analysis is on the source record.